Food Effect in Healthy Participants

2
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Crestone
CrestoneCO - Boulder
1 program
1
CRS3123 200 mg capsulePhase 11 trial
Active Trials
NCT06988423CompletedEst. Jun 2025
E
EisaiChina - Liaoning
1 program
1
E7386Phase 11 trial
Active Trials
NCT03996226Completed17Est. Oct 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
CrestoneCRS3123 200 mg capsule
EisaiE7386

Clinical Trials (2)

Total enrollment: 17 patients across 2 trials

NCT06988423CrestoneCRS3123 200 mg capsule

Evaluation of the Potential Impact of a High-fat Meal on the Pharmacokinetics of CRS3123 in Healthy Adult Participants

Start: May 2025Est. completion: Jun 2025
Phase 1Completed

A Food-Effect Study of E7386 in Healthy Participants

Start: Jun 2019Est. completion: Oct 201917 patients
Phase 1Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space